Myung-Ju has focused on early clinical trials for the development of drug discovery and repurposing of targeted drugs and the development of a NSCLC genome atlas. At the ASM, she will share her insight on targeted therapy and small cell lung cancer.
Myung-Ju has focused on early clinical trials for the development of drug discovery and repurposing of targeted drugs and the development of a NSCLC genome atlas. At the ASM, she will share her insight on targeted therapy and small cell lung cancer.
The Thoracic Oncology Group of Australasia Limited acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait cultures; and to Elders past and present.
PO Box 1103
Thornbury VIC 3071
Ph: +61 3 9087 3550
ABN: 47 641 984 198
Thoracic Oncology Group of Australasia is registered with the Australian Taxation Office as an Income Tax Exempt Charitable Entity. Donations $2 and over are tax deductible.
Copyright © 2024 TOGA – Thoracic Oncology Group Australasia. No part of this site may be reproduced without our written permission.
